<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02356146</url>
  </required_header>
  <id_info>
    <org_study_id>IRB225/56</org_study_id>
    <nct_id>NCT02356146</nct_id>
  </id_info>
  <brief_title>First Tacrolimus Dose Trough Level is Better Than CYP3A5 Genotyping in Tacrolimus Dose Prediction</brief_title>
  <official_title>First Tacrolimus Dose Trough Level is Better Than CYP3A5 Genotyping in Tacrolimus Dose Prediction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chulalongkorn University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tacrolimus dose highly varies among Asian kidney transplant recipients. This can be explained
      by variety of CYP3A5 expression. CYP3A5 genotyping is highly recommended for patients
      receiving tacrolimus. Here, we assessed the tacrolimus dose prediction by comparing CYP3A5
      expression and tacrolimus dosage using tacrolimus concentration after single dose
      administration prior to kidney transplantation.

      Plasma tacrolimus trough level was measured at 12 hours after first dose of 0.1 mg/kg of
      tacrolimus (TacC12), orally administered in 51 new kidney transplant recipients. Patients
      with CYP3A5 inhibitor/inducer co-medications were excluded. Genotyping for CYP3A5 expression
      were carried out by RT-PCR. The dosages of tacrolimus at post-operative day 7 and dosage
      which provided stable therapeutic levels in post-operative month 1 to 3 (C0 5-8 ng/mL) were
      recorded.

      The genotyping, TacC12, and target tacrolimus dosage have good correlations.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>target tacrolimus dose at 3 months</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>rate of rejection</measure>
    <time_frame>3-12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rate of CNI toxicity</measure>
    <time_frame>2-12 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Kidney Transplantation Recipients</condition>
  <arm_group>
    <arm_group_label>All KT recipient</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tacrolimus C12</intervention_name>
    <arm_group_label>All KT recipient</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood level for tacrolimus was took 12 hours after first dose.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All KT recipient who transplanted and will be transplanted in King Chulalongkorn Memorial
        Hospital from 2012-2015
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All KT recipients

        Exclusion Criteria:

          -  Recipient who not receiving tacrolimus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Natavudh Townamchai, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Natavudh Townamchai, MD</last_name>
    <phone>+66894904222</phone>
    <email>ntownamchai@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chulalongkorn University and King Chulalongkorn Memorial Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natavudh Townamchai, MD</last_name>
      <phone>+66894904222</phone>
      <email>ntownamchai@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 1, 2015</study_first_submitted>
  <study_first_submitted_qc>February 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 5, 2015</study_first_posted>
  <last_update_submitted>February 1, 2015</last_update_submitted>
  <last_update_submitted_qc>February 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 5, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chulalongkorn University</investigator_affiliation>
    <investigator_full_name>Natavudh Townamchai, MD</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Kidney transplantation</keyword>
  <keyword>genotype</keyword>
  <keyword>tacrolimus</keyword>
  <keyword>CYP3A5</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tacrolimus</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

